Trial Profile
Prospective pilot study of the pharmacokinetics and pharmacodynamics of interaction between tipranavir/ritonavir and raltegravir in patients infected with HIV-1. [Estudio piloto prospectivo de la farmacocinetica y farmacodinamia de la interaciion entre tipranavir/ritonavir y raltegravir en pacientes infectados por el VIH-1.]
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2014
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Ritonavir; Tipranavir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 25 Aug 2011 New trial record